These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 6245565)
21. A comparison of des-amino arginine vasopressin with pitressin tannate as diagnostic agents. Hocken AG N Z Med J; 1979 May; 89(636):381-2. PubMed ID: 289006 [TBL] [Abstract][Full Text] [Related]
23. [DDAVP loading test (a test on kidney concentrating ability)]. Shimizu K Nihon Rinsho; 1979 Jun; Suppl():2519-20. PubMed ID: 491203 [No Abstract] [Full Text] [Related]
24. Absence of overlapping resistance to vasopressin and parathyroid hormone in patients with nephrogenic diabetes insipidus and pseudohypoparathyroidism. Moses AM; Coulson BB J Clin Endocrinol Metab; 1982 Oct; 55(4):699-702. PubMed ID: 7107814 [No Abstract] [Full Text] [Related]
25. [Possibilities in the determination of kidney concentrating ability as based on the DDAVP [deamino-(8-D-arginine)-vasopressin] test]. Nádvorníková H; Schück O; Cort JH Vnitr Lek; 1978 Oct; 24(10):1026-31. PubMed ID: 706183 [No Abstract] [Full Text] [Related]
26. Detection of renal impairment in cases of chronic abuse of analgesics by administration of desamino-D-arginine vasopressin. Wambach G; Bönner G; Kleinpass H; Dopatka A; Kaufmann W Arzneimittelforschung; 1989 Mar; 39(3):387-90. PubMed ID: 2569306 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of diabetes insipidus with synthetic vasopressin derivatives (effect of 1-deamino-8-D-arginine vasopressin and 1-deamino-valine-8-D-arginine vasopressin)]. Czakó L; László F; Manning M Orv Hetil; 1980 Mar; 121(13):773-8. PubMed ID: 7383655 [No Abstract] [Full Text] [Related]
30. [Adiuretin (DDAVP) test for renal concentrating ability in infants]. Lehotská V; Lichardus B; Némethová V; Skultétyová M Cesk Pediatr; 1981 Jun; 36(6):324-7. PubMed ID: 7273216 [No Abstract] [Full Text] [Related]
31. Desamino arginine vasopressin (DDAVP) as a diagnostic agent. Somerfield SD; Hocken AG N Z Med J; 1977 Nov; 86(600):472-3. PubMed ID: 343010 [TBL] [Abstract][Full Text] [Related]
36. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus. Laczi F; Mezei G; Julesz J; Lázló FA Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552 [TBL] [Abstract][Full Text] [Related]
37. Reduction of renal prostaglandin E formation in essential hypertension. Weber PC; Scherer B; Held E; Siess W Adv Prostaglandin Thromboxane Res; 1980; 7():1145-8. PubMed ID: 6989183 [No Abstract] [Full Text] [Related]
38. A case of familial central diabetes insipidus: the response of urinary prostaglandins to 1-deamino-8-D-arginine vasopressin. Sasaki Y; Higashihara E; Takeuchi T; Nutahara K; Homma Y; Aso Y J Urol; 1994 Jul; 152(1):161-3. PubMed ID: 8201652 [TBL] [Abstract][Full Text] [Related]
39. Diabetes insipidus: a postpartum complication. Tulandi T; Yusuf N; Posner BI Obstet Gynecol; 1987 Sep; 70(3 Pt 2):492-5. PubMed ID: 3498136 [TBL] [Abstract][Full Text] [Related]
40. Hemodynamic and hormonal effects of low or high sodium hemodialysis. Krämer BK; Ress KM; Ulshöfer TM; Risler T Kidney Int Suppl; 1988 Sep; 25():S192-5. PubMed ID: 3054238 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]